Northwestern Mutual Wealth Management’s Aerie Pharmaceuticals AERI Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-150	Closed	-$3K	–	3220
2021 Q1	$3K	Buy	+150	New	+$2.59K	﹤0.01%	2570
2020 Q1	–	Sell	-160	Closed	-$4K	–	2818
2019 Q4	$4K	Sell	160 -140	-47%	-$2.9K	﹤0.01%	2143
2019 Q3	$6K	Buy	+300	New	+$6.87K	﹤0.01%	2071
2017 Q1	–	Sell	-98	Closed	-$4K	–	2499
2016 Q4	$4K	Buy	+98	New	+$3.71K	﹤0.01%	1928

Other funds holding AERI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Northwestern Mutual Wealth Management's AERI Position: Q2 2021 in Review

Northwestern Mutual Wealth Management sold out of Aerie Pharmaceuticals (AERI) in Q2 2021, closing a stake of 150 shares — an estimated $3K sold.

Northwestern Mutual Wealth Management first reported a position in AERI in Q4 2016 and held it in 4 quarters. The position peaked at $6K in Q3 2019. 142 funds tracked by Wall St. Rank hold AERI as of Q2 2021.

Northwestern Mutual Wealth Management reported no remaining Aerie Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 150 Aerie Pharmaceuticals shares in Q2 2021, an estimated $3K.
Northwestern Mutual Wealth Management first reported a position in Aerie Pharmaceuticals in Q4 2016 and held it in 4 quarters.
Northwestern Mutual Wealth Management's Aerie Pharmaceuticals position peaked at $6K in Q3 2019.
142 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2021.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2021, filed 13 Aug 2021.